Product news from the 12/12/06 news brief
Millennium Pharmaceuticals received FDA approval to market Velcade for the treatment of patients with mantle cell lymphoma (MCL) who have ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.